SCHEMBL683595

SCHEMBL683595

CC(C)c1ccccc1OCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.58
MAPT P10636 1/20 0.58
MAPK1 P28482 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
LIPE Q05469 1/20 0.53
SGMS2 Q8NHU3 11/20 0.53
ALDH1A1 P00352 4/20 0.53
LMNA P02545 3/20 0.53
NISCH Q9Y2I1 1/20 0.53
HTR1A P08908 2/20 0.50
CYP1A2 P05177 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ADRA1D P25100 1/20 0.50
ADRA1A P35348 1/20 0.50
ADRA1B P35368 1/20 0.50
DRD2 P14416 1/20 0.50
GLRA1 P23415 1/20 0.49
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formaldehyde SCHEMBL27774094 0.95 TDP1 (0.53) L3MBTL1MAPTMAPK1TDP1LIPE
SCHEMBL27753371 0.90 GLRA1 (0.49) L3MBTL1MAPTMAPK1TDP1LIPE
SCHEMBL18430835 0.86 NISCH (0.55) L3MBTL1MAPTMAPK1TDP1SGMS2
SCHEMBL10094328 0.86 MAPT (0.51) L3MBTL1MAPTMAPK1TDP1LIPE
SCHEMBL23046945 0.85 MAPT (0.55) L3MBTL1MAPTMAPK1TDP1LIPE
SCHEMBL9460741 0.85 MAPT (0.55) L3MBTL1MAPTMAPK1TDP1LIPE
SCHEMBL3458384 0.85 TDP1 (0.55) L3MBTL1MAPTMAPK1TDP1LIPE
SCHEMBL25146420 0.85 MAPK1 (0.53) L3MBTL1MAPTMAPK1TDP1LIPE
SCHEMBL24449689 0.84 MAPT (0.54) L3MBTL1MAPTMAPK1TDP1LIPE
Hydrochloric Acid SCHEMBL9460764 0.84 MAPT (0.53) L3MBTL1MAPTMAPK1TDP1LIPE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210221784-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PAIN UNIVERSITÉ DE STRASBOURG (FR) 2021-07-22 US disclosed
US-10206931-B2 Therapeutic compounds and uses thereof GENENTECH, INC. (US) 2019-02-19 US disclosed
US-20170312292-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF WUXI APPTEC (SHANGHAI) CO. LTD (CN) 2017-11-02 US disclosed
US-20170312292-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF WUXI APPTEC (SHANGHAI) CO. LTD (CN) 2017-11-02 US disclosed
US-20170144984-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE UNITED STATES OF AMERICA AS REPRESENTED BY SECRETARY DEPT OF HEALTH AND HUMAN SERVICE (US) 2017-05-25 US disclosed
US-20170144984-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE UNITED STATES OF AMERICA AS REPRESENTED BY SECRETARY DEPT OF HEALTH AND HUMAN SERVICE (US) 2017-05-25 US disclosed
US-9452973-B2 Modulators of the relaxin receptor 1 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2016-09-27 US disclosed
US-9133186-B2 Hetero ring-fused imidazole derivative having AMPK activating effect SHIONOGI & CO., LTD. (JP) 2015-09-15 US disclosed
US-9115122-B2 Non-ATP dependent inhibitors of extracellular signal-regulated kinase (ERK) UNIVERSITY OF MARYLAND, BALTIMORE (US) 2015-08-25 US disclosed
US-20150216168-A1 USE OF SUBSTITUTED 2-AMIDOBENZIMIDAZOLES, 2-AMIDOBENZOXAZOLES AND 2-AMIDOBENZOTHIAZOLES OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2015-08-06 US disclosed
US-20130184240-A1 HETERO RING-FUSED IMIDAZOLE DERIVATIVE HAVING AMPK ACTIVATING EFFECT SHIONOGI & CO., LTD. (JP) 2013-07-18 US disclosed
WO-2013016531-A2 COMPOUNDS AND METHODS FOR USE IN TREATING NEOPLASIA AND CANCER PURDUE RESEARCH FOUNDATION (US) 2013-01-31 WO disclosed
US-8268803-B2 5, 6-ring annulated indole derivatives and use thereof MERCK SHARP & DOHME CORP. (US) 2012-09-18 US disclosed
US-20110269717-A1 NEUROGENESIS BY MODULATING ANGIOTENSIN BRAINCELLS INC. (US) 2011-11-03 US disclosed
US-20100322901-A1 5, 6-RING ANNULATED INDOLE DERIVATIVES AND USE THEREOF SCHERING CORPORATION 2010-12-23 US disclosed
EP-1718605-B1 PROCESSES FOR THE PREPARATION OF ARYL-AND HETEROARYL-ALKYLSULFONYL HALIDES WYETH CORP (US) 2009-06-17 EP disclosed
US-20070066652-A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof ASTRAZENECA AB (SE) 2007-03-22 US disclosed
US-20070066652-A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof ASTRAZENECA AB (SE) 2007-03-22 US disclosed
EP-0486745-A1 Improved solvents for chromogens useful in the manufacture of carbonless copying paper MONSANTO EUROPE S.A./N.V. (BE) 1992-05-27 EP disclosed
US-3968320-A Dye solvents for pressure-sensitive record material MONSANTO COMPANY (US) 1976-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210221784-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PAIN ACHE, TRPV1, OPRL1 L3MBTL1 4614/4885MAPT 572/4885MAPK1 2946/4885
US-20130184240-A1 HETERO RING-FUSED IMIDAZOLE DERIVATIVE HAVING AMPK ACTIVATING EFFECT PRKAA1, PRKAA2, PRKAG1 L3MBTL1 2717/4885MAPT 3580/4885MAPK1 360/4885
US-20110269717-A1 NEUROGENESIS BY MODULATING ANGIOTENSIN NGF, DCX, BDNF L3MBTL1 4624/4885MAPT 1368/4885MAPK1 470/4885
US-20170312292-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF EP300, CREBBP, HDAC1 L3MBTL1 2291/4885MAPT 2745/4885MAPK1 579/4885
US-20070066652-A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof OPRM1, OPRD1, OPRL1 L3MBTL1 2271/4885MAPT 4006/4885MAPK1 2503/4885
US-10206931-B2 Therapeutic compounds and uses thereof EP300, CREBBP, HDAC1 L3MBTL1 2291/4885MAPT 2745/4885MAPK1 579/4885
US-20100322901-A1 5, 6-RING ANNULATED INDOLE DERIVATIVES AND USE THEREOF IDO1, IDO2, TPH1 L3MBTL1 1796/4885MAPT 1314/4885MAPK1 4217/4885
US-20150216168-A1 USE OF SUBSTITUTED 2-AMIDOBENZIMIDAZOLES, 2-AMIDOBENZOXAZOLES AND 2-AMIDOBENZOTHIAZOLES OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS ABAT, AAK1, AGXT L3MBTL1 2857/4885MAPT 2879/4885MAPK1 957/4885
US-20170144984-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 RXFP1, RXFP2, RXFP3 L3MBTL1 3143/4885MAPT 4541/4885MAPK1 1480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.